香港股市 已收市

Edwards Lifesciences Corporation (EW)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
85.94-0.51 (-0.59%)
收市:04:00PM EDT
86.00 +0.06 (+0.07%)
收市後: 05:55PM EDT

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500
https://www.edwards.com

版塊Healthcare
行業Medical Devices
全職員工19,800

高階主管

名稱頭銜支付行使價出生年份
Mr. Bernard J. ZovighianCEO & Director2.27M1968
Mr. Scott B. UllemCorporate VP & CFO1.35M6.36M1967
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development1.27M2.68M1962
Mr. Larry L. WoodCorporate VP and Group President of TAVR & Surgical Structural Heart1.49M2.13M1966
Dr. Todd J. Brinton FACC, M.D.Corporate VP of Advanced Technology & Chief Scientific Officer
Mark WilterdingVice President of Investor Relations
Mr. Arnold A. PinkstonCorporate VP & General Counsel1959
Mr. Dirksen J. LehmanCorporate Vice President of Public Affairs
Ms. Christine Z. McCauleyCorporate Vice President of Human Resources1965
Mr. Gary I. SorsherSenior Vice President of Quality & Regulatory Compliance1965
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

公司管治

截至 2024年4月1日 止,Edwards Lifesciences Corporation 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中:4;董事會:5;股東權利:4;現金賠償:3。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。